ARAY Accuray Inc

  1. Stocks
  2. Healthcare
  3. NASDAQ: ARAY

Price (delayed)

$2.66

Market cap

$258.21M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.07

Enterprise value

$384.43M

Accuray is committed to expanding the powerful potential of radiation therapy to improve as many lives as possible. The company invents unique, market-changing solutions that are designed to deliver radiation ...

Highlights
The EPS has grown by 36% YoY and by 30% from the previous quarter
The net income has grown by 30% year-on-year and by 27% since the previous quarter
ARAY's equity is up by 8% YoY but it is down by 5% QoQ
The quick ratio has declined by 8% since the previous quarter and by 6% year-on-year
The gross margin has declined by 6% year-on-year
Sector: Healthcare
Industry: Medical Devices
Website: http://www.accuray.com
Peers: HOLX ICAD SYK

Key stats

What are the main financial stats of ARAY
Market
Shares outstanding
97.07M
Market cap
$258.21M
Enterprise value
$384.43M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
5.04
Price to sales (P/S)
0.56
EV/EBIT
N/A
EV/EBITDA
203.94
EV/Sales
0.84
Earnings
Revenue
$455M
EBIT
-$2.72M
EBITDA
$1.89M
Free cash flow
-$5.53M
Per share
EPS
-$0.07
Free cash flow per share
-$0.06
Book value per share
$0.53
Revenue per share
$4.71
TBVPS
$4.34
Balance sheet
Total assets
$476.83M
Total liabilities
$425.89M
Debt
$204.9M
Equity
$50.94M
Working capital
$132.7M
Liquidity
Debt to equity
4.02
Current ratio
1.66
Quick ratio
0.77
Net debt/EBITDA
66.96
Margins
EBITDA margin
0.4%
Gross margin
34.9%
Net margin
-1.5%
Operating margin
1.5%
Efficiency
Return on assets
-1.4%
Return on equity
-12.9%
Return on invested capital
-0.8%
Return on capital employed
-1%
Return on sales
-0.6%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

ARAY stock price

How has the Accuray stock price performed over time
Intraday
-3.27%
1 week
0%
1 month
-0.75%
1 year
31.68%
YTD
27.27%
QTD
-2.21%

Financial performance

How have Accuray's revenue and profit performed over time
Revenue
$455M
Gross profit
$158.86M
Operating income
$6.78M
Net income
-$6.8M
Gross margin
34.9%
Net margin
-1.5%
The company's operating margin has surged by 200% QoQ and by 88% YoY
The company's operating income has surged by 185% QoQ and by 91% YoY
Accuray's net margin has increased by 35% YoY and by 29% QoQ
The net income has grown by 30% year-on-year and by 27% since the previous quarter

Growth

What is Accuray's growth rate over time

Valuation

What is Accuray stock price valuation
P/E
N/A
P/B
5.04
P/S
0.56
EV/EBIT
N/A
EV/EBITDA
203.94
EV/Sales
0.84
The EPS has grown by 36% YoY and by 30% from the previous quarter
The price to book (P/B) is 8% lower than the 5-year quarterly average of 5.5 and 4.9% lower than the last 4 quarters average of 5.3
ARAY's equity is up by 8% YoY but it is down by 5% QoQ
The price to sales (P/S) is 20% lower than the 5-year quarterly average of 0.7 and 7% lower than the last 4 quarters average of 0.6
Accuray's revenue has increased by 9% YoY

Efficiency

How efficient is Accuray business performance
The ROS has soared by 63% YoY and by 60% from the previous quarter
The ROIC has soared by 62% YoY and by 60% QoQ
Accuray's ROE has increased by 33% YoY and by 28% from the previous quarter
The company's return on assets rose by 33% YoY and by 30% QoQ

Dividends

What is ARAY's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for ARAY.

Financial health

How did Accuray financials performed over time
The company's total assets is 12% higher than its total liabilities
The quick ratio has declined by 8% since the previous quarter and by 6% year-on-year
Accuray's current ratio has decreased by 4.6% YoY and by 2.4% QoQ
The company's debt to equity fell by 8% YoY but it rose by 5% QoQ
ARAY's equity is up by 8% YoY but it is down by 5% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.